{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:51:15Z","timestamp":1791244275840,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.blre.2010.03.003","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T04:44:58Z","timestamp":1271825098000},"page":"123-134","source":"Crossref","is-referenced-by-count":155,"title":["The genetic basis of von Willebrand disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Anne C.","family":"Goodeve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2010.03.003_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2010.03.003_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2010.03.003_bib4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib5","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1073\/pnas.89.8.3531","article-title":"Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly","volume":"89","author":"Mayadas","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2010.03.003_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0037-1615884","article-title":"Molecular genetics of von Willebrand disease","volume":"82","author":"Ginsburg","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0037-1614927","article-title":"Factor VIII and von Willebrand factor","volume":"79","author":"Vlot","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib8","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI112129","article-title":"Substructure of human von Willebrand factor","volume":"76","author":"Fowler","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2010.03.003_bib9","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2010.03.003_bib10","unstructured":"VWFdb. International Society on Thrombosis and Haemostasis Scientific and Standardization Committee VWF Information Homepage. http:\/\/www.vwf.group.shef.ac.uk\/, accessed January 2010."},{"key":"10.1016\/j.blre.2010.03.003_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","article-title":"Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction","volume":"30","author":"Mancuso","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.blre.2010.03.003_bib12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V70.4.895.895","article-title":"Willebrand factor and von Willebrand disease","volume":"70","author":"Ruggeri","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105.","article-title":"The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-0037-1616109","article-title":"Recommended abbreviations for von Willebrand Factor and its activities","volume":"86","author":"Mazurier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib17","unstructured":"HGNC. HUGO Gene Nomenclature Committee information homepage. http:\/\/www.genenames.org\/, accessed January 2010."},{"key":"10.1016\/j.blre.2010.03.003_bib18","unstructured":"HGVS. Human Genome Variation Society. Nomenclature for the description of sequence variations homepage. http:\/\/www.hgvs.org\/mutnomen\/ accessed January 2010."},{"issue":"s2","key":"10.1016\/j.blre.2010.03.003_bib19","first-page":"OC-TU-076","article-title":"Functional characterisation of 13-bp deletion mutation (-1255 del) in the VWF gene promoter causing type 1 von Willebrand disease","volume":"7","author":"Othman","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.febslet.2008.12.058","article-title":"The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision?","volume":"583","author":"Silva","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.blre.2010.03.003_bib21","doi-asserted-by":"crossref","unstructured":"Plate M., Duga S., Baronciani L., La Marca S., Rubini V., Mannucci P.M., et al. Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay. Haematologica 2010;95:172-4.","DOI":"10.3324\/haematol.2009.012336"},{"key":"10.1016\/j.blre.2010.03.003_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/humu.20212","article-title":"Microdeletions and microinsertions causing human genetic disease: common mechanisms of mutagenesis and the role of local DNA sequence complexity","volume":"26","author":"Ball","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.blre.2010.03.003_bib23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nrg2193","article-title":"Gene conversion: mechanisms, evolution and human disease","volume":"8","author":"Chen","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.blre.2010.03.003_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib25","series-title":"Textbook of Haemophilia:","article-title":"von Willebrand disease: molecular aspects","author":"Goodeve","year":"2010"},{"key":"10.1016\/j.blre.2010.03.003_bib26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1538-7836.2008.02945.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)","volume":"6","author":"Budde","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.blre.2010.03.003_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1538-7836.2009.03381.x","article-title":"Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance","volume":"7","author":"Castaman","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib29","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1160\/TH07-09-0565","article-title":"Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations","volume":"99","author":"Millar","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib30","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1538-7836.2003.00359.x","article-title":"Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?","volume":"1","author":"Brown","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib31","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib32","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib33","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000214848","article-title":"C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels","volume":"121","author":"Davies","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2010.03.003_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1538-7836.2007.02809.x","article-title":"Willebrand factor: evidence for variable clearance in vivo according to Y\/C1584 phenotype and ABO blood group","volume":"6","author":"Davies","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib36","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2006-07-035105","article-title":"Effect of von Willebrand factor Y\/C1584 on in vivo protein level and function and interaction with ABO blood group","volume":"109","author":"Davies","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib37","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood-2008-01-133181","article-title":"Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo","volume":"112","author":"van Schooten","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib38","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2009.03486.x","article-title":"Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study","volume":"7","author":"Eikenboom","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib39","first-page":"A193","article-title":"A novel recurrent deletion mutation associated with type 1 and type 3 von Willebrand disease","volume":"141s1","author":"Sutherland","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.03.003_bib40","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood-2009-04-218099","article-title":"When 1 plus 1 equals 3 in VWD","volume":"114","author":"Goodeve","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib41","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand Disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib42","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1182\/blood-2008-11-190850","article-title":"Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study","volume":"113","author":"Daly","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib43","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-2516.2008.01813.x","article-title":"The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network","volume":"14","author":"Keeney","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2010.03.003_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0038-1657568","article-title":"Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM Network on Molecular Abnormalities in von Willebrand Disease","volume":"78","author":"Meyer","year":"1997","journal-title":"Thromb Haemost"},{"issue":"Suppl 5","key":"10.1016\/j.blre.2010.03.003_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2516.2008.01849.x","article-title":"Diagnosis of von Willebrand disease subtypes: implications for treatment","volume":"14","author":"Budde","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2010.03.003_bib46","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1538-7836.2005.01219.x","article-title":"Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutations","volume":"3","author":"O'Brien","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00894-004-0194-9","article-title":"Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations","volume":"10","author":"Sutherland","year":"2004","journal-title":"J Mol Model"},{"key":"10.1016\/j.blre.2010.03.003_bib48","doi-asserted-by":"crossref","first-page":"15647","DOI":"10.1073\/pnas.0705175104","article-title":"Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi","volume":"104","author":"Purvis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2010.03.003_bib49","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1182\/blood-2003-12-4286","article-title":"A novel type 2A von Willebrand factor mutation located at the last nucleotide of exon 26 (3538G>A) causes skipping of 2 nonadjacent exons","volume":"104","author":"James","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib50","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1538-7836.2009.03457.x","article-title":"Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization","volume":"7","author":"Baronciani","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib51","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1160\/TH07-05-0347","article-title":"A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis","volume":"98","author":"Casonato","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib52","unstructured":"Nurden P., Gobbi G., Nurden A., Enouf J., Youlyouz-Marfak I., Carubbi C., et al. Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from von Willebrand disease type 2B patients. Blood."},{"key":"10.1016\/j.blre.2010.03.003_bib53","unstructured":"PT-VWD-Registry. Registry on platelet type von Willebrand disease. http:\/\/www.pt-vwd.org\/ accessed January 2010."},{"key":"10.1016\/j.blre.2010.03.003_bib54","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2141.2006.06078.x","article-title":"Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance","volume":"133","author":"Enayat","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.03.003_bib55","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2007.02666.x","article-title":"Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib56","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1055\/s-0037-1616142","article-title":"Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen","volume":"86","author":"Ribba","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib57","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2008-10-184317","article-title":"Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor","volume":"114","author":"Riddell","year":"2009","journal-title":"Blood"},{"issue":"S1","key":"10.1016\/j.blre.2010.03.003_bib58","first-page":"S14","article-title":"Mutations leading to reduced von Willebrand factor binding to factor VIII are uncommon among patients referred for type 2N von Willebrand disease genetic analysis","volume":"20","author":"Goodeve","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2010.03.003_bib59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood.V79.3.563.563","article-title":"The mutation Arg (53)\u2013\u2013Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor","volume":"79","author":"Jorieux","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1160\/TH04-02-0084","article-title":"Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization","volume":"92","author":"Schneppenheim","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2516.2005.01111.x","article-title":"The molecular analysis of haemophilia A: a guideline from the UK haemophilia centre doctors' organization haemophilia genetics laboratory network","volume":"11","author":"Keeney","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2010.03.003_bib62","first-page":"758","article-title":"Duplication of exon 13 causes one third of the cases of mild hemophilia A in northern Italy","volume":"89","author":"Acquila","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2010.03.003_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000214855","article-title":"Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene","volume":"121","author":"Gadisseur","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2010.03.003_bib64","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/hmg\/2.5.545","article-title":"In-frame deletion of von Willebrand factor A domains in a dominant type of von Willebrand disease","volume":"2","author":"Bernardi","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.blre.2010.03.003_bib65","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/geno.1994.1241","article-title":"Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin","volume":"21","author":"Zhang","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.blre.2010.03.003_bib66","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2516.2009.02059.x","article-title":"The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England","volume":"15","author":"Sutherland","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2010.03.003_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bcmd.2008.03.004","article-title":"Genetic defects in von Willebrand disease type 3 in Indian and Greek patients","volume":"41","author":"Gupta","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2010.03.003_bib68","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2010.03.003_bib69","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-08-173278","article-title":"A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3","volume":"114","author":"Sutherland","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib70","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1538-7836.2008.03107.x","article-title":"An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary","volume":"6","author":"Mohl","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1538-7836.2007.02460.x","article-title":"A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3","volume":"5","author":"Schneppenheim","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib72","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/nar\/gnf056","article-title":"Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification","volume":"30","author":"Schouten","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.blre.2010.03.003_bib73","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib74","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1538-7836.2008.03182.x","article-title":"Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease","volume":"6","author":"Bowman","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib75","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood.V98.1.248","article-title":"Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development","volume":"98","author":"Surdhar","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib76","first-page":"348","article-title":"Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor","volume":"125","author":"Bergamaschini","year":"1995","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2010.03.003_bib77","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood-2002-12-3693","article-title":"Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease","volume":"102","author":"O'Brien","year":"2003","journal-title":"Blood"},{"issue":"s2","key":"10.1016\/j.blre.2010.03.003_bib78","first-page":"P-T-189","article-title":"Rate of de novo VWF mutations in patients historically diagnosed with type 1 VWD in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"5","author":"Goodeve","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib79","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1538-7836.2009.03594.x","article-title":"Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function","volume":"7","author":"Flood","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib80","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3324\/haematol.10633","article-title":"The association between the L1565 variant of von Willebrand factor and susceptibility to proteolysis by ADAMTS13","volume":"92","author":"Davies","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2010.03.003_bib81","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2008.07266.x","article-title":"ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor","volume":"143","author":"Pruss","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.03.003_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood-2002-04-1046","article-title":"An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant","volume":"101","author":"Casonato","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib83","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1160\/TH06-03-0157","article-title":"Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide","volume":"96","author":"Hilbert","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.03.003_bib84","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2141.2003.04163.x","article-title":"Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity","volume":"120","author":"Hilbert","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.03.003_bib85","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","article-title":"Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor","volume":"95","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.03.003_bib86","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2141.2002.03488.x","article-title":"Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents","volume":"117","author":"Caron","year":"2002","journal-title":"Br J Haematol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X10000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X10000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T19:14:30Z","timestamp":1711394070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X10000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0268960X10000135"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2010.03.003","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}